Silk Medical Aesthetics, a spin-off of green chemistry company Evolved By Nature, has completed enrollment in a clinical trial for the dermatology industry’s reportedly first silk-based dermal filler, it reports.
Silk Medical Aesthetics has licensed Evolved By Nature’s technology, combining its proprietary Activated Silk technology with hyaluronic acid to develop a reversible dermal filler that aims to introduce a new level of customization to the marketplace and enable surgeons to administer injections with greater precision, according to the company in a media release.
Silk Medical Aesthetics’ composite filler concept leverages Evolved By Nature’s Activated Silk technology which aims to yield unique mechanical, rheological and optical properties not possible with traditional hyaluronic acid. Activated Silk is made by dissolving the pure silk fibroin protein in a simple saltwater solution.
This solution has the potential to be tailored to elicit different properties best suited for any volume filling application in the skin, from superficial to deep injections, as well as the treatment of acne scars, the release continues.
“Despite their widespread popularity, dermal fillers have seen little innovation over the last 20 years,” Silk Medical Aesthetics co-founder Greg Altman says.
“The Activated Silk technology is a huge leap forward for dermal fillers, as it introduces a new level of customization from a natural and biocompatible protein unseen in the market until now. We look forward to continuing our research and eventually working with leading dermatologists and plastic surgeons to introduce our silk-based solution to patients.”
This news comes on the heels of Silk Medical Aesthetics’ dermal filler recently being named to ELLE magazine’s first-ever Future of Beauty Awards. The company’s injectable dermal filler concept was named a winner in the New Injectables category, per the release.
[Source(s): Silk Medical Aesthetics, PR Newswire]
